Crinetics Pharmaceuticals, Inc. Debt Securities, Realized Gain (Loss)
Crinetics Pharmaceuticals, Inc. (CRNX) reported Debt Securities, Realized Gain (Loss) of $51.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesRealizedGainLoss · last filed 2025-02-27
- Crinetics Pharmaceuticals, Inc. debt securities, realized gain (loss) for fiscal 2024 was $51.00K.
- Crinetics Pharmaceuticals, Inc. debt securities, realized gain (loss) for fiscal 2023 was $0.00.
- Crinetics Pharmaceuticals, Inc. debt securities, realized gain (loss) for fiscal 2022 was -$86.00K, a 4400.00% decline from fiscal 2021.
- Crinetics Pharmaceuticals, Inc. debt securities, realized gain (loss) for fiscal 2021 was $2.00K, a 99.90% decline from fiscal 2020.
| Period end | Debt Securities, Realized Gain (Loss) 12 month | Debt Securities, Realized Gain (Loss) 12 month as first filed |
|---|---|---|
| 2024-12-31 | $51.00K 10-K · filed 2025-02-27 | |
| 2023-12-31 | $0.00 10-K · filed 2025-02-27 | |
| 2022-12-31 | -$86.00K 10-K · filed 2025-02-27 | |
| 2021-12-31 | $2.00K 10-K · filed 2024-02-28 | $2.00M 10-K · filed 2022-03-30 |
| 2020-12-31 | $2.00M 10-K · filed 2023-02-28 | $26.00M 10-K · filed 2022-03-30 |
| 2019-12-31 | $26.00M 10-K · filed 2023-02-28 | $7.00M 10-K · filed 2022-03-30 |